B12 Labs provides an AI-powered software platform that automates and accelerates chemical synthesis for the pharmaceutical and biotechnology industries. Its tools assist researchers with retrosynthesis planning, reaction condition optimization, and the generation of execution-ready protocols for lab automation equipment.
Subscribe to see b12 Labs’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
b12 Labs is an ai/ml company headquartered in United States. Xcout tracks 2 named people at b12 Labs, including Zlatko Jončev (Co-Founder & CEO). Xcout recorded 1 job posting from b12 Labs in the last 90 days.
Xcout recorded 1 job posting from b12 Labs in the last 90 days, from a hiring record Xcout has kept since May 2026.
The weekly hiring trend, the roles and locations behind it — see b12 Labs's hiring signals →
A few of b12 Labs's closest competitors — see the full list of competitors and alternatives →
PostEra Inc. is a U.S.-based biotechnology company that develops machine-learning and computational chemistry software for drug discovery and medicinal chemistry. Its platform helps pharmaceutical and biotechnology organizations design, prioritize, and manage experiments for small-molecule therapeutics.
Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
AION Labs is a venture studio headquartered in Rehovot, Israel. It is dedicated to building and investing in startups that leverage AI to revolutionize drug discovery and development, connecting pharma R&D with new AI, technology, and scientific innovation.
Inceptive is a data-driven lab focused on AI medicines, creating tools for the rational design of novel biomolecules and biological software. The company has offices in Palo Alto, Berlin, and Zurich, and is pioneering the next generation of AI-driven medical advancements.
Omec.AI is an Israeli startup founded in 2022 and headquartered in Rehovot, Israel, supported by AION Labs. The company is developing an AI-driven computational platform designed to help pharmaceutical researchers assess the clinical trial readiness of drug candidates by analyzing pre-clinical safety and efficacy data.
Pepticom operates an artificial intelligence-driven drug discovery platform focused on designing and optimizing novel therapeutic peptides. The company utilizes reinforcement learning, generative AI, and computational algorithms to develop drug candidates for both internal programs and industry collaborations.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.